2019
Author response to Letter to the Editor: ‘Dynamics of platelet count after sustained virologic response do not mirror those of hepatic venous pressure gradient’
Ortiz GA, Sayyar M, Garcia‐Tsao G. Author response to Letter to the Editor: ‘Dynamics of platelet count after sustained virologic response do not mirror those of hepatic venous pressure gradient’. Liver International 2019, 40: 990-991. PMID: 31749290, DOI: 10.1111/liv.14302.Commentaries, Editorials and Letters
2018
Regression of HCV cirrhosis: Time will tell
Garcia‐Tsao G. Regression of HCV cirrhosis: Time will tell. Hepatology 2018, 67: 1651-1653. PMID: 29222930, PMCID: PMC6016365, DOI: 10.1002/hep.29720.Commentaries, Editorials and Letters
2015
High risk of delisting or death in liver transplant candidates following infections: Results from the North American consortium for the study of end‐stage liver disease
Reddy KR, O'Leary JG, Kamath PS, Fallon MB, Biggins SW, Wong F, Patton HM, Garcia‐Tsao G, Subramanian RM, Thacker LR, Bajaj JS, Disease F. High risk of delisting or death in liver transplant candidates following infections: Results from the North American consortium for the study of end‐stage liver disease. Liver Transplantation 2015, 21: 881-888. PMID: 25845966, DOI: 10.1002/lt.24139.Peer-Reviewed Original ResearchConceptsEnd-stage liver diseaseLiver transplantationOrgan failureNorth American ConsortiumLiver diseaseUnderwent transplantationMELD scoreMedian ageEnd-stage liver disease (MELD) scoreTertiary-care hepatology centersAmerican ConsortiumExtrahepatic organ failureMean MELD scoreLiver Disease scoreLiver transplant candidatesPatients' median ageHepatitis C virusType of infectionPrevention of infectionHepatology centersTransplant candidatesCirculatory failureC virusInfected patientsHigh risk
2005
Comparison of hepatitis C treatment patterns in patients with and without psychiatric and/or substance use disorders†
Chainuvati S, Khalid S, Kancir S, Shea M, Edwards J, Sernyak M, Wongcharatrawee S, Garcia‐Tsao G. Comparison of hepatitis C treatment patterns in patients with and without psychiatric and/or substance use disorders†. Journal Of Viral Hepatitis 2005, 13: 235-241. PMID: 16611189, DOI: 10.1111/j.1365-2893.2005.00681.x.Peer-Reviewed Original ResearchConceptsCompletion of therapyVirological responsePatient demographicsSubstance useAntiviral therapyMental illnessHepatitis C virus infectionLiver disease characteristicsC virus infectionNIH Consensus ConferenceType of therapyLiver clinicSVR ratesHCV RNAPositive patientsRelative contraindicationTherapy completionTreatment patternsLiver diseaseTreatment eligibilityDisease characteristicsPatient populationPoor adherenceVirus infectionConsensus conference
1997
Viral RNA in duodenal bile of cirrhotic patients with chronic hepatitis C.
Kuan S, Garcia-Tsao G, Cartun R, Emanuel J, West A. Viral RNA in duodenal bile of cirrhotic patients with chronic hepatitis C. Archives Of Pathology & Laboratory Medicine 1997, 121: 847-52. PMID: 9278613.Peer-Reviewed Original ResearchConceptsHepatitis C virusCirrhotic patientsDuodenal bileChronic hepatitis C virusHepatitis C virus RNAHCV-negative controlsChronic hepatitis C.C virus RNAReverse transcriptase-polymerase chain reactionViral RNATranscriptase-polymerase chain reactionCross-reacting antigenSeropositive patientsHepatitis C.Seronegative controlsEndoscopic evaluationBreast milkC virusPolymerase chain reactionCirrhotic liverC100 proteinAntigen immunoreactivePatientsBileVirus RNA
1995
Treatment of chronic hepatitis C.
García-Tsao G. Treatment of chronic hepatitis C. Revista De Gastroenterología De México 1995, 60: s52-3. PMID: 8948779.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements